Article
16 Jul 2024
The USPTO's "Experimental Use Exception Request For Comments"
AUTHORS CONTENT
Article
28 Mar 2023
ChromaDex Fails To Milk Its Patent For Subject Matter Eligibility
Article
14 Dec 2022
Inequitable Conduct Claim Can Progress Even After The Case Is Complete
Article
12 Dec 2022
Inequitable Conduct Claim Can Proceed Even After The Case Is Over
Article
11 Oct 2022
Roche Wins Reprieve From $137 Million Jury Verdict
Article
10 Oct 2022
Written Description Support Pre-AIA Scuttles PGR
Article
09 May 2022
Defendants Allowed To Hide The Ball On Their Combination Of Prior Art References
Article
08 Apr 2022
How Sweet It Smells: Examiner Rejection Of Composition Claims Reversed
Article
14 Mar 2022
ANDA Specification Controls Infringement Analysis, Not Expert Testimony
Article
20 Jan 2022
"Show More Of You": Amgen V. Sandoz, Battling It Out On Amgen's Otezla® Drug
Article
04 Dec 2021
Patent Owner Loses Everything At PTAB
Article
02 Dec 2021
Considerations For Innovators When Navigating Patent Eligibility On The International Stage
Article
10 Nov 2021
Formulation And Administration Claims Asserted In Hatch-Waxman Pass Muster
Article
28 Sep 2021
Federal Circuit Crystallizes BMS' Apixaban District Court Win
Article
21 Sep 2021
Testing The Limits Of Therasense: Patent Owner's Decision Not To Appeal Obviousness Holding Created But-for Materiality And Knowledge Of Withheld References Established Intent
Article
19 Oct 2020
US Patent Law Year In Review: October 2019 - September 2020
Article
27 Apr 2018
Inherency In Obviousness—A Worrying Trend?